Background: The risks for anaphylaxis among intravenous (IV) iron products currently in use
have not been assessed. Objective: To compare risks for anaphylaxis among 5 IV iron …

Importance All intravenous (IV) iron products are associated with anaphylaxis, but the
comparative safety of each product has not been well established. Objective To compare the …

Abstract Introduction and Objective Intravenous iron preparations rapidly correct iron
deficiency anemia, with the notable drug class effect of rare, yet potentially life-threatening …

Importance Although iron deficiency is common, it remains unclear which iron repletion
strategy is associated with the lowest rate of infusion-related adverse events, and how …

Spontaneously-reported rates of adverse events (AEs) of intravenous (iv) iron products have
not been compared since 2007. AEs in Europe (Eur) and North America (NA) have never …

Controversy exists about the safety of the parenteral iron dextran products, Dexferrum and
INFeD, which have been associated with rare, serious anaphylactic‐type reactions. In the …

Aims Intravenous iron supplementation is widely used to treat iron deficiency and iron
deficiency anemia when oral iron administration is ineffective or poorly tolerated …

Among many physicians, it is generally thought that intravenous (IV) iron has an inherent
risk of serious adverse events (SAE). Earlier preparations of highmolecular-weight iron …

Concerns persist about adverse reactions to intravenous (IV) iron. We aimed to determine
the relative safety of ferumoxytol compared to other IV iron compounds. This retrospective …

Background. Reliable information on the incidence of severe reactions to iron dextran is
limited. Administration of agents of resuscitation in acute anaphylaxis may serve as a marker …